Free Trial

20 Stocks Wall Street Analysts Love the Most - 10 of 20

 
 

Encompass Health (NYSE:EHC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
10 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$100.38 (8.1% Upside)

About Encompass Health

Encompass Health logoEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/15/2024Truist FinancialBoost Price TargetBuy ➝ Buy$100.00 ➝ $104.00
8/8/2024UBS GroupBoost Price TargetBuy ➝ Buy$96.00 ➝ $100.00
8/6/2024StephensReiterated RatingOverweight ➝ Overweight$105.00 ➝ $105.00
8/6/2024BarclaysLower Price TargetOverweight ➝ Overweight$113.00 ➝ $109.00
7/15/2024Truist FinancialBoost Price TargetBuy ➝ Buy$95.00 ➝ $100.00
7/10/2024BarclaysBoost Price TargetOverweight ➝ Overweight$108.00 ➝ $113.00
7/10/2024Leerink PartnrsUpgradeStrong-Buy
7/10/2024Leerink PartnersInitiated CoverageOutperform$100.00
6/5/2024StephensReiterated RatingOverweight ➝ Overweight$94.00 ➝ $94.00
5/22/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$83.00 ➝ $95.00
 

Trump’s weapon lurks in abandoned America (Ad)

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary